1. Home
  2. BHVN vs ASGN Comparison

BHVN vs ASGN Comparison

Compare BHVN & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • ASGN
  • Stock Information
  • Founded
  • BHVN 2013
  • ASGN 1985
  • Country
  • BHVN United States
  • ASGN United States
  • Employees
  • BHVN N/A
  • ASGN N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • ASGN Professional Services
  • Sector
  • BHVN Health Care
  • ASGN Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • ASGN Nasdaq
  • Market Cap
  • BHVN 3.6B
  • ASGN 4.2B
  • IPO Year
  • BHVN 2017
  • ASGN 1992
  • Fundamental
  • Price
  • BHVN $36.17
  • ASGN $84.18
  • Analyst Decision
  • BHVN Strong Buy
  • ASGN Buy
  • Analyst Count
  • BHVN 13
  • ASGN 5
  • Target Price
  • BHVN $63.00
  • ASGN $103.40
  • AVG Volume (30 Days)
  • BHVN 1.1M
  • ASGN 386.1K
  • Earning Date
  • BHVN 11-12-2024
  • ASGN 02-05-2025
  • Dividend Yield
  • BHVN N/A
  • ASGN N/A
  • EPS Growth
  • BHVN N/A
  • ASGN N/A
  • EPS
  • BHVN N/A
  • ASGN 3.96
  • Revenue
  • BHVN N/A
  • ASGN $4,188,800,000.00
  • Revenue This Year
  • BHVN N/A
  • ASGN N/A
  • Revenue Next Year
  • BHVN $197.10
  • ASGN $1.86
  • P/E Ratio
  • BHVN N/A
  • ASGN $21.18
  • Revenue Growth
  • BHVN N/A
  • ASGN N/A
  • 52 Week Low
  • BHVN $26.80
  • ASGN $82.75
  • 52 Week High
  • BHVN $62.21
  • ASGN $106.42
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 33.02
  • ASGN 38.66
  • Support Level
  • BHVN $36.70
  • ASGN $82.75
  • Resistance Level
  • BHVN $42.13
  • ASGN $90.45
  • Average True Range (ATR)
  • BHVN 2.84
  • ASGN 2.26
  • MACD
  • BHVN -0.67
  • ASGN -0.40
  • Stochastic Oscillator
  • BHVN 13.18
  • ASGN 24.57

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About ASGN ASGN Incorporated

ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.

Share on Social Networks: